Yungjin Pharm Co Ltd Cash Flow-to-Debt Ratio
Yungjin Pharm Co Ltd cash flow-to-debt ratio. Yungjin Pharm Co Ltd (003520) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of ₩7.00 Billion could theoretically repay 0% of its total liabilities (₩156.23 Billion) in one year. Check how high is Yungjin Pharm Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Yungjin Pharm Co Ltd (2013–2024)
Cash flow-to-debt ratio of Yungjin Pharm Co Ltd from 2013 to 2024. Historical debt coverage capacity for Yungjin Pharm Co Ltd across 12 annual periods. Check 003520 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Yungjin Pharm Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2024)
Yungjin Pharm Co Ltd cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Yungjin Pharm Co Ltd. For the full cash flow conversion analysis, see 003520 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | ₩21.74 Billion | ₩144.45 Billion | ▲ +301.6% |
| 2023 | -0.07x | ₩-10.22 Billion | ₩136.97 Billion | ▲ +27.2% |
| 2022 | -0.10x | ₩-11.61 Billion | ₩113.21 Billion | ▼ -209.3% |
| 2021 | 0.09x | ₩8.37 Billion | ₩89.21 Billion | ▼ -52.3% |
| 2020 | 0.20x | ₩14.50 Billion | ₩73.67 Billion | ▲ +79.6% |
| 2019 | 0.11x | ₩9.28 Billion | ₩84.69 Billion | ▲ +626.9% |
| 2018 | 0.02x | ₩1.27 Billion | ₩84.51 Billion | ▼ -59.7% |
| 2017 | 0.04x | ₩3.15 Billion | ₩84.20 Billion | ▲ +12.1% |
| 2016 | 0.03x | ₩3.11 Billion | ₩93.19 Billion | ▼ -64.6% |
| 2015 | 0.09x | ₩8.80 Billion | ₩93.27 Billion | ▲ +18.7% |
| 2014 | 0.08x | ₩6.22 Billion | ₩78.18 Billion | ▼ -10.7% |
| 2013 | 0.09x | ₩5.95 Billion | ₩66.89 Billion | — |